The contraindications it lists are personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, and severe pancreatitis, none of which is hypothyroidism
Once breastfeeding is complete, your healthcare provider can discuss the full range of GLP-1 options, including compounded semaglutide injection, oral semaglutide, or the Precision Peptide Genetic Test (offered at $99 as an add-on after your first month of treatment)
Safety Considerations and When to Contact Your Provider While nausea, mild vomiting, and constipation within 2472 hours are expected, persistent vomiting beyond 5 days, severe dehydration, rapid heart rate, or signs of pancreatitis (severe upper abdominal pain radiating to the back) warrant immediate medical attention
However, it should be noted that none of the included studies provided explicit descriptions regarding the implementation of allocation concealment or experimenter blinding procedures